LncRNA-HLX-2-7/HLX axis-dependent metabolic reprogramming drives cancer progression in group 3 medulloblastoma. - Katsushima K; Sanada Y; Scott DA; Stapleton S; Jallo G; Eberhart CG; Perera RJ (Acta neuropathologica communications, 2026)